Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
Clinical trial NCT03711422 · TERMINATED
Trial details
- NCT number
- NCT03711422
- Sponsor
- National Cancer Centre, Singapore
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-16
- Primary completion
- 2019-12-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.